Education Library

Resources for Health Care Professionals

Filter Results

Condition

Audience

Topic

Type

November 8, 2021

TCT 2021: Primary Results from the OPTIMUM Registry

Adam Salisbury, MD, presents the primary results from the OPTIMUM Registry, a late breaker at TCT 2021.

November 4, 2021

TCT 2021: MCS During High-Risk PCI and PROTECT IV

Gregg Stone, MD, reviews evidence for the use of mechanical circulatory support during high-risk PCI and provides an overview of the PROTECT IV RCT.

November 3, 2021

Best Practices for Treating High-Risk PCI Patients

Jason Wollmuth, MD, discusses large-bore access and intravascular imaging best practices for treating high-risk PCI patients.

November 3, 2021

Improved Outcomes with Contemporary Practices in PROTECT III

Jeffrey Moses, MD, discusses the improved outcomes with contemporary practices seen in the PROTECT III study of Impella-supported high-risk PCI.

November 3, 2021

HFSA 2021: Identifying Patients for PROTECT IV

Navin Kapur, MD, explains the importance of identifying patients with heart failure who can be enrolled in the PROTECT IV trial.

November 3, 2021

Protected PCI as a Practical Approach to MCS in Elective Complex Cases

William O’Neill, MD, discusses Protected PCI as a practical approach to mechanical circulatory support in elective complex PCI cases.

November 2, 2021

HFSA 2021: Clinical Evidence to Support ‘On-Pump’ Complex PCI in Heart Failure

Navin Kapur, MD, discusses clinical evidence to support ‘on-pump’ complex PCI for patients with heart failure.

October 26, 2021

HFSA 2021: MCS in High-Risk PCI Evidence from PROTECT II through PROTECT IV

Gregg Stone, MD, reviews available data—from PROTECT II through PROTECT IV—for use of mechanical circulatory support during high-risk PCI.

October 20, 2021

Innovative Single-Access Dry Field Closure Technique

Hady Lichaa, MD, discusses an innovative single-access dry-closure technique with iliac artery angioplasty through the ipsilateral sheath.

October 4, 2021

Trends in Outcomes of High-Risk pVAD-Assisted PCI

Alejandro Lemor, MD, MS, discusses his recently published paper on trends in outcomes between 2008 and 2018 in high-risk pVAD-assisted PCI.

September 20, 2021

Jason Wollmuth, MD, Presents RESTORE EF Data at HFSA 2021

Jason Wollmuth, MD, presents the latest data from the RESTORE EF study at the HFSA Annual Scientific Meeting in September 2021.

July 8, 2021

Protected PCI for Superior Long-Term Outcomes

Gregg Stone, MD, and Duane Pinto, MD, host this panel discussion from SCAI 2021 of Protected PCI and diagnosis and treatment of high-risk and complex coronary disease.

May 20, 2021

CRT 2021: PROTECT IV and Beyond with Rajan Patel, MD

Rajan Patel, MD, discusses clinical data supporting Impella® use in Protected PCI and cardiogenic shock at the CRT 2021 virtual annual symposium. 

April 15, 2021

First Patient Enrolled in PROTECT IV Randomized Controlled Trial of Impella® Heart Pumps

The PROTECT IV RCT will leverage advancements in technology and best practices learned since the completion of the PROTECT II RCT and the FDA pre-market approval for Impella 2.5® for high-risk PCI. 

February 23, 2021

Impact of Impella® on Dissected Coronary Artery Hemodynamics

Kiyotake Ishikawa, MD, discusses his paper on the impact of Impella on dissected coronary artery hemodynamics in a porcine model.

NPS-1674